Evidence map›Paper›PMID 37115296›Full record

ArticleAnnals of hematology2023

Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.

Marina Belia, Ioannis Drandakis, Eleftheria Lakiotaki, Maria Arapaki, Fotios Panitsas, Evangelia-Fedra Triantafyllou, Eleni Plata, Marina P Siakantaris, Maria K Angelopoulou, Penelope Korkolopoulou and 1 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Marina BeliaDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Ioannis DrandakisDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Eleftheria LakiotakiDepartment of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Maria ArapakiDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Fotios PanitsasDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Evangelia-Fedra TriantafyllouDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Eleni PlataDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Marina P SiakantarisDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Maria K AngelopoulouDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Penelope KorkolopoulouDepartment of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Theodoros P VassilakopoulosDepartment of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece. tvassilak@med.uoa.gr.ORCID 0000-0001-8766-1853
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, B-CellLymphoma, Large B-Cell, DiffuseAgedAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinEtoposideHumansPrednisoneTreatment OutcomeVincristineCyclophosphamideDoxorubicinEtoposidePrednisoneVincristine

Identifiers

PMID37115296
OpenAlexW4367318209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.